Phio Pharmaceuticals (PHIO) Earnings Analysis

Phio Pharmaceuticals (PHIO) next reports earnings on 2026-08-13, consensus EPS -0.36 USD. Last quarter (2026-05-07) it missed with EPS -0.34 USD vs -0.24 USD est (-41.7%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -0.74.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PHIO next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.36 USD
Revenue estimaten/a

PHIO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.34 USD-0.24 USD-41.7%Miss
2026-03-05-0.15 USD-0.34 USD+55.9%Beat
2025-11-13-0.44 USD-0.45 USD+2.2%Beat
2025-08-14-0.45 USD-0.36 USD-25%Miss
2025-05-15-0.41 USDn/an/an/a
2025-03-31-0.85 USD-1.23 USD+30.9%Beat
2024-11-14-1.54 USD-4.14 USD+62.8%Beat
2024-08-14-3.62 USD-4.59 USD+21.1%Beat

Beat rate: 5/7 (71%) over reported quarters with consensus data.

PHIO valuation and analyst view

Trailing P/E-0.74
Trailing EPS-0.94101 USD
Price / book0.75
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Phio Pharmaceuticals (PHIO)'s next earnings date?

Phio Pharmaceuticals is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.36 USD.

Did PHIO beat earnings last quarter?

In its 2026-05-07 report, PHIO posted EPS of -0.34 USD versus a -0.24 USD estimate — a miss of 41.7%.

What is PHIO's earnings track record?

Over the last 7 reported quarters with consensus data, PHIO beat estimates 5 times (71%).

What is PHIO's current P/E ratio and EPS?

PHIO trades at a trailing P/E of -0.74 on trailing EPS of -0.9410144397340162 USD.

What do analysts rate PHIO?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).